Bronchiectasis: Clinical Trials

31 trials for Bronchiectasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

14 completed, 8 unknown, 6 recruiting, 2 terminated. 31 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 431Completed 14, Unknown 8, Recruiting 6, Terminated 2, Withdrawn 1

Follow Bronchiectasis: new trials by email Literature Review of Bronchiectasis trials Research Report on Bronchiectasis

Trials (filtered) newest first · largest first

All 31 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Itraconazole Therapy In Bronchiectasis With Airway Mold
Itraconazole 200 mg - Bronchiectasis, Fungal Infection of Upper Respiratory Tract
Phase 4RecruitingMayo Clinic302026-08-172026-08-21
Azithromycin to Modify Bronchiectasis Exacerbation Risk
Standard Bronchiectasis Care, Azithromycin, Matching Placebo - Non-cystic Fibrosis Bronchiectasis, Bronchiectasis Adult
Phase 4RecruitingAssiut University5002026-06-292026-09-24
Clinical Study on the Treatment of Stable Bronchiectasis With Bailing Capsules Combined With Guben Kechuan Granules
Bailing Capsules in combination Guben Kechuan Granules - Bronchiectasis, COPD
Phase 4RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine2142025-07-142025-08-11
Hypertonic Saline in NCFB
7% Hypertonic Saline via nebulization - Bronchiectasis, Non-cystic Fibrosis Bronchiectasis
Phase 4RecruitingUniversity of North Carolina, Chapel Hill202024-10-232025-08-13
Vitamin D Replacement in Bronchiectasis
Vitamin D3 - Bronchiectasis
Phase 4RecruitingQueen Mary Hospital, Hong Kong1042024-04-172024-08-13
Tobramycin Inhalation Solution for Pseudomonas Aeruginosa Eradication in Bronchiectasis
Tobramycin Inhalant Product, Ciprofloxacin 750 MG, Oral ciprofloxacin placebo - Bronchiectasis Adult, Pseudomonas Aeruginosa Infection
Phase 4CompletedJin-Fu Xu3712023-10-182026-04-17
Bronchoscopic Levofloxacin, Gentamicin, or Sham for Acute Exacerbation of Bronchiectasis
Local instillation of gentamicin and Budesonide, Local instillation of Levofloxacin and Budesonide, Bronchoscopic mechanical secretion suction and lavage - Bronchiectasis With Acute Exacerbation
Phase 4RecruitingAssiut University3152023-10-152025-07-17
Ceftolozane/Tazobactam Continuous Infusion for Infective Exacerbations of Cystic Fibrosis and Bronchiectasis
Ceftolozane/tazobactam - Bronchiectasis, Cystic Fibrosis
Phase 4UnknownSunshine Coast Hospital and Health Service302023-10-012023-09-13
Immunoglobulin Replacement Therapy for Immunoglobulin G Subclass 2 Deficient Patients With Bronchiectasis
Cuvitru 20 % Injectable Solution - Bronchiectasis, Immunoglobulin Subclass Deficiency
Phase 4WithdrawnUniversity of Edinburgh2022-08-052021-09-29
Trial on The Efficacy of Hypertonic Saline on Non-CF CSLD.
Nebulized 5% Hypertonic saline - Bronchiectasis
Phase 4CompletedUniversity of Malaya462021-02-042023-12-01
A Series of N-of-1 Trials of Traditional Chinese Medicine Based on Bayesian Method
Individualized Decoction, placebo, Tested drug minus heat-clearing herbs - Bronchiectasis, Quality of Life
Phase 4UnknownShanghai University of Traditional Chinese Medicine712019-12-012020-10-26
Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis
Aztreonam lysine, Placebo - Bronchiectasis Adult
Phase 4TerminatedUniversity of Dundee342019-10-192026-01-12
Targeted AntiBiotics for Chronic Pulmonary Diseases
Piperacillin/tazobactam, Ciprofloxacin - COPD, Respiratory Tract Infections
Phase 4TerminatedChronic Obstructive Pulmonary Disease Trial Network, Denmark512018-01-102023-05-25
Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis
Symbicort, Spiriva - COPD, Bronchiectasis
Phase 4UnknownShanghai Pulmonary Hospital, Shanghai, China902017-09-152019-08-01
Evaluating the Effects of Traditional Chinese Medicine by N-of-1 Trials
Individualized Decoction, placebo, Tested drug minus heat-clearing herbs - Bronchiectasis, Quality of Life
Phase 4UnknownShanghai University of Traditional Chinese Medicine362017-03-012017-05-10
Prevention of OM-85 on Bronchiectasis Exacerbation
OM-85 BV - Bronchiectasis With Acute Exacerbation
Phase 4CompletedChinese Academy of Medical Sciences1962015-03-012020-04-21
Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis
Cholecalciferol, Placebo - Bronchiectasis
Phase 4UnknownShanghai Pulmonary Hospital, Shanghai, China2002015-01-012015-07-24
Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis
Bronchoalveolar Lavage and Local Amikacin Injection - Bronchiectasis
Phase 4UnknownShanghai Pulmonary Hospital, Shanghai, China1002014-12-012018-08-22
Bacterial Load Guided Therapy for Severe Bronchiectasis Exacerbations
Duration, Colomycin, Meropenem - Bronchiectasis
Phase 4CompletedUniversity of Edinburgh902014-01-012020-05-04
The Role of Theophylline Plus Low-dose Formoterol-budesonide in Treatment of Bronchiectasis
Formoterol-budesonide, Theophylline, Placebo - Bronchiectasis
Phase 4CompletedThe First Affiliated Hospital of Guangzhou Medical University502013-07-012015-03-11

Showing 20 of 31. Sign in to see all of them.

Narrower conditions

Pseudomonas Infections (4)  ·  Pulmonary Disease, Chronic Obstructive (4)  ·  Inflammation (2)  ·  Asthma (1)  ·  Bronchitis, Chronic (1)  ·  Burkholderia Infections (1)  ·  Chronic Cough (1)  ·  Cystic Fibrosis (1)  ·  Fibrosis (1)  ·  Respiratory Tract Infections (1)  ·  Sarcoidosis (1)

Broader conditions

Bronchial Diseases (31)  ·  Respiratory Tract Diseases (31)  ·  Pathological Conditions, Signs and Symptoms (8)  ·  Pathologic Processes (7)  ·  Infections (5)  ·  Lung Diseases (5)  ·  Bacterial Infections (4)  ·  Bacterial Infections and Mycoses (4)  ·  Chronic Disease (4)  ·  Disease Attributes (4)  ·  Gram-Negative Bacterial Infections (4)  ·  Lung Diseases, Obstructive (4)  ·  Hypersensitivity (2)  ·  Immune System Diseases (2)  ·  Bronchitis (1)

Interventions

Sodium Chloride (3)  ·  Atorvastatin (2)  ·  Azithromycin (2)  ·  Cholecalciferol (2)  ·  Ciprofloxacin (2)  ·  Theophylline (2)  ·  Anti-Bacterial Agents (1)  ·  Aztreonam (1)  ·  Broncho-Vaxom (1)  ·  Bronchoalveolar Lavage (1)  ·  Budesonide (1)  ·  Budesonide, Formoterol Fumarate Drug Combination (1)  ·  Fluticasone-Salmeterol Drug Combination (1)  ·  Gentamicins (1)  ·  Hizentra (1)

Sponsors

University of Edinburgh (5)  ·  Shanghai Pulmonary Hospital, Shanghai, China (4)  ·  Assiut University (2)  ·  NHS Lothian (2)  ·  Shanghai University of Traditional Chinese Medicine (2)  ·  The First Affiliated Hospital of Guangzhou Medical University (2)  ·  Chinese Academy of Medical Sciences (1)  ·  Chronic Obstructive Pulmonary Disease Trial Network, Denmark (1)  ·  Jin-Fu Xu (1)  ·  Mayo Clinic (1)  ·  Penang Hospital, Malaysia (1)  ·  Queen Mary Hospital, Hong Kong (1)  ·  Second Affiliated Hospital, Zhejiang University, School of Medicine (1)  ·  Shandong University (1)  ·  Sunshine Coast Hospital and Health Service (1)

Countries

China (12)  ·  United Kingdom (8)  ·  United States (3)  ·  Egypt (2)  ·  Malaysia (2)  ·  Denmark (1)  ·  Hong Kong (1)  ·  Italy (1)

Top investigators

Adam T Hill, MBChB MD (5)  ·  Chen Rongchang, Professor (2)  ·  Jin-Fu Xu (2)  ·  Zhong Nanshan, Professor (2)  ·  Adam T Hill, MBCHB, MRCP, MD (1)  ·  Adam T Hill, MD, FRCPE (1)  ·  Ahmad M Shaddad, MD (1)  ·  Ahmad M. Shaddad, MD (1)  ·  Alaa S. Ali (1)  ·  Ali A Ali, MSc (1)  ·  Aliae A Hussien, MD (1)  ·  Aliae M. Hussien, MD (1)  ·  Amjad Kanj, MD (1)  ·  Andrew Burke, MBBS (1)

Results publications

PMID 20870753, PMID 11511368, PMID 12403874, PMID 1285737, PMID 12927665, PMID 15672845, PMID 15741443, PMID 16650970, PMID 17053496, PMID 17931847, PMID 18006882, PMID 18828160, PMID 19541717, PMID 20585638, PMID 20864608, PMID 21330456, PMID 21398686, PMID 21458735, PMID 21697993, PMID 21778259, PMID 21830316, PMID 21885727, PMID 22018993, PMID 22349069, PMID 22744718, PMID 22947443, PMID 23076388, PMID 23101012, PMID 23146374, PMID 23371406, PMID 23630581, PMID 23646159, PMID 23898922, PMID 24232697, PMID 24482322, PMID 24521788, PMID 24671923, PMID 24717640, PMID 24773830, PMID 24872685, PMID 24913725, PMID 24952426, PMID 25183304, PMID 25307313, PMID 25477988, PMID 25516281, PMID 25638182, PMID 26842959, PMID 27214047, PMID 28232410

NIH funding

2018 (1)